Nykode Therapeutics AS (OSL: NYKD)

Nykode Therapeutics AS Revenue

Nykode Therapeutics AS had revenue of $665.00K USD in the quarter ending September 30, 2024, a decrease of -76.34%. This brings the company's revenue in the last twelve months to $4.37M, down -69.90% year-over-year. In the year 2023, Nykode Therapeutics AS had annual revenue of $13.32M with 47.56% growth.

• Revenue (ttm): $4.37M
• Revenue Growth: -69.90%
• P/S Ratio: 18.60
• Revenue / Employee: $25.26K
• Employees: 173
• Market Cap: 971.15M NOK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	13.32M	4.29M	47.56%
Dec 31, 2022	9.03M	-26.74M	-74.76%
Dec 31, 2021	35.77M	-179.93M	-83.42%
Dec 31, 2020	215.70M	214.28M	15,175.85%
Dec 31, 2019	1.41M	-10.63M	-88.27%